Prothena Corp Public (PRTA) EPS (Diluted) Growth (3y) (2016 - 2026)
Prothena Corp Public (PRTA) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 78.99% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.28% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.39% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 83.94% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 38.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.86% |
| Dec 31, 2025 | -70.84% |
| Sep 30, 2025 | 11.33% |
| Jun 30, 2025 | -38.38% |
| Mar 31, 2025 | -12.90% |
| Dec 31, 2024 | -16.39% |
| Sep 30, 2024 | -35.98% |
| Jun 30, 2024 | 27.79% |
| Mar 31, 2024 | -13.75% |
| Dec 31, 2023 | -18.11% |
| Sep 30, 2023 | 35.60% |
| Jun 30, 2023 | -16.00% |
| Mar 31, 2023 | -14.75% |
| Dec 31, 2022 | 31.00% |
| Sep 30, 2022 | -16.30% |
| Jun 30, 2022 | -20.59% |
| Mar 31, 2022 | -5.40% |
| Dec 31, 2021 | 1.45% |
| Sep 30, 2021 | 67.88% |
| Jun 30, 2021 | 32.11% |